Asthma
COPD
Devices
100

Preferred reliever strategy in modern asthma guidelines combining bronchodilation and anti-inflammatory effect

What is: PRN low dose ICS-formoterol

100

Initial maintenance therapy for symptomatic COPD without frequent exacerbations

What is: A bronchodilator

100

Device covering LABA/LAMA/ICS combination

What is: Trelegy Ellipta, Enerzair Breezhaler

200

This short acting bronchodilator is associated with tachycardia, tremors and palpilations

What is: SABA
200

Blood eosinophil threshold warranting ICS therapy

What is: > 300 cells/uL

200
Inhalation device compatible with Aerochambers

What is: MDI

300

This short acting bronchodilator has a slower onset than it's short acting counterpart

What is: SAMA

300

Important ICS adverse effect risk in COPD

What is: pneumonia risk

300

This inhaler type might not be compatible with a person with low coordination or dexterity

What is: Handihaler, Breezhaler

400

Uncontrolled asthma on low dose ICS-formoterol MART, what is the next common pharmacologic escalation?

What is: increase to medium dose of ICS-formoterol for maintenance

400

First pharmacologic escalation is symptoms persist on single long acting bronchodilator

What is: dual bronchodilator therapy (LABA/LAMA)

400

This inhaler type has audio/visual dose confirmation

What is: Genuair DPI

500

During early asthma exacerbation, some action plans recommend temporarily increasing this ICS medication dose up to this amount.

What is: quadrupling ICS dose

500

High risk COPD exacerbation history per CTS definition

What is: 2+ moderate exacerbations or 1+ severe exacerbation

500

This inhaler type doesn't require high inspiratory force

What is: Respimat, MDI (with spacer)